chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2//20/2021 - Vaccine administered at 10am, strong pounding headache began about 5 hours later- aspirin.  Headaches returned for the next couple of days.  03/13/2021 - Vaccine administered at vaccine center at 10am: at 10 pm (12 hours) strong headache began - 2 aspirin x 250mg - at midnight (14 hours) chills began and lasted until about 7am (3/14/2021), then dizziness, feeling dehydrated (drank a LOT of water) and very tired.  This lasted until Monday 3/152021 about midday.  So, a draining 1 day flu.
Approx 1 hour after flu vaccine was given her mother noticed her face and neck were swollen although she herself did not notice this. Reports she slept about 3 hours after wards. Denies throat swelling, difficulty swallowing or breathing. Claims swelling was gone after 3 hour nap.
Patient presented with rash  (shingles) along right arm (same arm as vaccinated) and onto back. Patient states this appeared about one week after vaccine. Patient was prescribed acyclovir and the rash has been drying out slowly.
Fever Headache Fatigue-unable to stay awake Nausea Dizzy
dizzy; orthostatic hypotension; Kept waking up every two hours; nausea; arm pain and was sore; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm pain and was sore), DIZZINESS (dizzy), ORTHOSTATIC HYPOTENSION (orthostatic hypotension), SLEEP DISORDER (Kept waking up every two hours) and NAUSEA (nausea) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID (VITAMIN C ACID) and VITAMIN D NOS for an unknown indication.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain and was sore). On 18-Mar-2021, the patient experienced DIZZINESS (dizzy), ORTHOSTATIC HYPOTENSION (orthostatic hypotension), SLEEP DISORDER (Kept waking up every two hours) and NAUSEA (nausea). At the time of the report, PAIN IN EXTREMITY (arm pain and was sore), DIZZINESS (dizzy), ORTHOSTATIC HYPOTENSION (orthostatic hypotension), SLEEP DISORDER (Kept waking up every two hours) and NAUSEA (nausea) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  Action taken with mRNA-1273 in response to the events was not applicable   No treatment medications were provided.
This spontaneous report as received from a Registered Nurse refers to a multiple unspecified patient's of unknown age and gender, who on unspecified dates were vaccinated with a dose of VARIVAX (Merck) (dose, indication, route, site of administration and lot # were reported), that might have been subjected to significant light exposure. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed chickenpox with approximately 70-75 lesions. Follow up states the patient remained afebrile. The patient sought unspecified medical treatment. On an unspecified date, the patient recovered.
HIVES ON NECK, FACE, AND BACK WITHIN3 0 MINUTES OF VACCINATION TREATED WITH DIPHENHYDRAMINE HCL
DEEP VEIN THROMBOSIS (BLOOD CLOT); FELT UNWELL; SLIGHT HEADACHE; FELT TIRED; This spontaneous report received from a patient concerned a 79-year-old female. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, and other pre-existing medical conditions included the patient had not been tested positive for covid-19 and did not had covid-19. The patient experienced drug allergy when treated with ciprofloxacin, and pethidine. On 02-Apr-2021, the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: 1808980, and expiry: Unknown) dose was not reported, 1 total administered on left arm for prophylactic vaccination. Non-company suspect drugs included: rivaroxaban (form of admin, route of admin, and batch number were not reported) 15 mg, 2 times every 1 day, from APR-2021, and 15 mg, every 1 day, from 04-MAY-2021, frequency was not reported for deep vein thrombosis. The patient was not taking any concomitant medication while reporting.  On 03-Apr-2021, the patient experienced slight headache and felt tired. On the evening of 29-Apr-2021, the patient went to the hospital where the sonogram was performed. Laboratory data included: Sonogram (NR: not provided) Not reported. On Friday, 30-Apr-2021, the patient could hardly walk and had painful leg (pain in back of legs especially calf area and spreading) and on 30-Apr-2021, was admitted to the hospital. The hospital asked her to see family doctor. After discharge, the hospital told that patient had deep vein thrombosis (blood clot). The patient was prescribed Xarelto (rivaroxaban) in hospital and the patient went to family doctor next morning. The family doctor told her to start Xarelto. She was started on Xarelto 15 mg (30mg daily) twice a day from hospital discharge. The family doctor changed the dosage due to age and small size after 5 days to 15 mg daily because patient felt unwell on twice a day dose. The patient had been on Xarelto 15 mg daily since 04-May-2021. The patient would follow up with family doctor on 07-Jul-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight headache on 06-APR-2021, and was recovering from deep vein thrombosis (blood clot), and felt tired. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210556796-COVID-19 VACCINE AD26.COV2.S- Deep vein thrombosis. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
I woke up with severe case of vertigo. I vomited once. I laid down in bed all day with occasional need to use bathroom. I was able to keep down liquids during the day and was able to eat soup and 2 pieces of toast in early evening.
Received vaccine at 10am - 20 mins later felt slight prickly itching in both arms between armpit and elbow. Lasted about 10 minutes. Around 4pm the same day I had bad neck pain. And pounding heading, about 1 hour later starting getting chills and fatigued. By 10pm had body aches and muscles pains. I took some Motrin and went to bed. I couldn?t sleep as my mind kept racing. In the morning (day after vaccine) I was feeling worse. All symptoms continued in full force and I couldn?t get out of bed. 10am I was able to drink some Alka seltzer cold medicine and lay back down. I continued to have chills pounding headache bodyaches muscle aches and sweating, but no fever. I felt like I had a bad case of the flu. I?ve continued taking 600 mg Motrin every eight hours and this has helped with the pains and bodyaches. Day 3 woke up feeling much better, noticed a funny smell in my nose, I haven?t been blowing my nose or had any mucus, but I can?t explain the smell. I still have body aches and muscles pains.
blistering pain, flu like symptoms, headache, huge reddish rash around shot area (left arm) blurred vision, burning sensations for over a week duration
Approximately 2 hours after vaccine administration, pt had emesis and became unresponsive, was taken to ER.
Fever:16 hrs after immunization lasting 6-8 hours. Excessive crying with screaming continuous when awake- starting at 16 hours post immunization and lasting at least 36 hours. Did sleep for 9 hours in middle of period. Left thigh swollen and indurated: no erythema.
Information has been received from a physician concerning a 6-year-old healthy female who in August 2000, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The physician reported that on 15-AUG-2005, the patient developed mild breakthrough characterized by a few lesions. Unspecified medical attention was sought. Subsequently, the patient recovered from the mild breakthrough. Additional information has been requested.
Tinnitus and decreased hearing in left ear Headache on left side Stiff neck left side
This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 17-FEB-2015, the patient was vaccinated with a dose of MMR II (dose, injection site, route of administration, lot number and expiration date were not reported). It was also reported that the patient received two consecutive doses of MMR II, (dose, injection site, route of administration, lot number and expiration were not reported) on 16-MAR-2015 and 26-MAY-2015, respectively. No adverse symptoms were reported. Additional information has been requested.
Tinnitus of right ear; I couldn't fall asleep; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 24May2021 at 12:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression, subclinical hypothyroidism and allergy to soy bean and peanut. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 03May2021 at 12:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. The patient reported tinnitus of right ear since 24Jul2021, till the day of report (reported as till today). She could hear constant ringing sound from her right ear. This happened all the sudden at one night when she was trying to sleep. The patient never had tinnitus before. Initially it happened more frequent and the patient couldn't fall asleep, then it happened almost for a consecutive 7 days each month. The patient stated that tinnitus was most impactful at night when trying to sleep when surroundings was very quiet. The patient was diagnosed with depression and anxiety prior getting her first Pfizer vaccine, however at the time when tinnitus happened, she was feeling emotionally stable and calm. The patient wasn't having a panic attack or feeling anxious. Tinnitus just happened to her for no reason. The events tinnitus of right ear due to which the patient couldn't fall asleep resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus of right ear and couldn't fall asleep was not resolved at the time of this report.
Pain in (L) UE @ site, swollen axillary lymph nodes, weakness & decreased ROM.
Beginning at approx 16 hours after receiving the vaccine and continuing until approx 36 hours after the injection, I experienced fever of 100-101 that was relieved with ibuprofen and acetaminophen (alternating). Significant headache and fatigue also present during most of this time. Now  appears resolved.
Patient had episodes of shaking of the entire body 1 day after immunization. Per mom he had a fever. On my exam he was afebrile and had a right otitis media.
Patient reported fever after injection and significant body aches. Patient later reported distention, sensitivity and pain in both breasts and stiffness and pain within both hands. Patient later develop pain within the flank and costal region on the left side of the body. Patient saw a physician within approximately one month after last vaccination. X-rays of the region were negative. A diagnosis of muscle strain was offered at that time. No follow up was recommended.
improperly stored (6.7F for 46 hours) VARIVAX was administered to the patient; No adverse effects; improperly stored (6.7F for 46 hours) VARIVAX was administered to the patient; This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were not provided. Concomitant therapy included sterile diluent.  On 16-OCT-2018, improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number N031002, expiration date 03-NOV-2019; strength, dose and frequency were not reported) was subcutaneously vaccinated to the patient for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent (lot and expiration date unknown by the reporter). No adverse effects reported for the patient. The vaccine was store at temperature maximum of 6.7 F and the time frame was 46 hours, which was detected by a data logger. There is no previous temperature excursion.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA005815:
Information has been received from a medical assistant concerning a patient who on an unspecified date was vaccinated with the second dose of PNEUMOVAX 23. Subsequently the patient experienced redness to the area, fever and other injection site reactions. The patient sought unknown medical attention. At the time of the report, the patient's outcome was unknown. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
Vomiting- (R) arm- swollen, unable to move.  Numbness in fingers, swollen hand.
This case was reported by the sister of a consumer and described the occurrence of uncontrolled blood glucose level in a 55-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included diabetes mellitus and hepatitis C. Previous vaccination included 1st dose TWINRIX (GlaxoSmithKline) given on an unspecified date. Concurrent medications included Glipizide. On an unspecified date the subject received 2nd dose of TWINRIX (unknown). At an unspecified time after vaccination with TWINRIX, the subject experienced uncontrolled blood glucose level. Glucose levels of 240 were unusual for the subject and not being controlled by his oral medication glipizide. This case was assessed as medically serious by GSK. At the time of reporting the event was unresolved.
The patient had a heart attack and died at a local hospital morning of 1/19/2021.
Information has been received from a nurse concerning a 8-year-old female who on 02-AUG-2007 was vaccinated with a dose of Zostavax (Oka/Merck) instead of "the varicella vaccine," Varivax (Oka/Merck).  It is reported that the office was out of "the varicella one".  It is unspecified if medical attention was sought.  No adverse events were reported.  It is reported that this was a case of product confusion since the packing for both vaccines was similar.  This is one of several reports from the same source.  Additional information has been requested. Follow-up: THe H.M. also reported that the patient's sister was vaccinated with ZOSTAVAX instead of VARIVAX (WAES# 0708USA01160). This is one of several reports from the same source. Additional information is not expected.
Stiffness of body for 1/2 hr approx 4 hrs p/DTP/HIB/OPV vax; later tongue smacking; never had fever; had 3 loose green stools; adm to hosp exam was nl & EEG nl;
Positive reaction:   Positive  Wife and himself had shingles shot about 10 days ago and he has already had a problem for the last several months with COVID with neuropathy, pins and needles in his legs.  His neuropathy has eased up to a degree, not completely gone, but he can get up and work outside like he has had in the past.  He?s 85 years old.  He wanted to report a positive report that we are in the business to investigate and somebody will look into the serum for shingles shots and see if there is something that can be developed to a higher degree or get some survey?s and to see if they are having the same positive effect that he has had from the vaccine to help thousands of people with neuropathy.  Now he can get outside where he was not able to get out before since the vaccine.   He still continues to be able to get around and hopes that the 2nd vaccine he is to get continues to improve his condition.    Had COVID pretty bad in July of 2022 and neuropathy started after that in September/October in his legs.  He went to the doctor for this and he prescribed the Gabapentin to him.  He upped the dose from 100 mg to 400 mg in November as the lower dose was not doing anything, and was still being bothered by it so the dose was increased.
Information has been received from a medical assistant concerning a 11 year old female patient whowas vaccinated intramuscularly with the first and second dose of GARDASIL (lot#663453/0249Y for both doses) 0.5 mL on 29-SEP-2009 and 11-NOV-2009 respectively. The medical assistant reported that on 29-SEP-2009 the patient developed hives on left arm (time of onset unknown). Then 5 days after second vaccination with of GARDASIL, on 16-NOV-2009, the patient developed hives all over body. It was noted that the patient was in a hot tub prior to reported hives. The patient was treated with BENADRYL and ZYRTEC. On an unspecified date the patient had recovered. The hives was considered an other important medical event by the medical assistant. Additional information is not expected.
Child developed a fever of 106F on 6/1/17. Fever down to 102F after spongebath and tylenol. Patient with slight rash on forehead and cheek. Temp 101.5F by evening of 6/1/17 and fever resolved by 6/2/17. 6/3/17: Fever up to 104F, resolved by 6/4/17. 6/12/17: Left upper thigh with a cluster of lesions mildly erythematous. 4 scattered raised lesions, painful to touch. Widespread rash noted.  8/22/17: patient presented with 4 days of low grade temp around 100F, vomiting post bottles and looser stool a few times day. Rash present for 4 days. Parents report since vaccination the patient has been more tired, she has not been crawling, talking, or walking. As of 8/22/17 she is slowly returning to her usual self.
She did get a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (She did get a sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Swollen glands (The patient reports she had swollen gland on her throat.).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (She did get a sore arm). At the time of the report, PAIN IN EXTREMITY (She did get a sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: Outcome of the event is updated to recovered or resolved.  Reporter said she was feeling fine and declined further follow-up.
This spontaneous report was received from a certified medical assistant concerning unspecified number of patients of unknown age and gender. No medical history or concurrent conditions were reported. On unknown dates, between 02-AUG-2015 and 31-AUG-2015, the unspecified patients were vaccinated with (Merck) VARIVAX that was improperly stored (dose, strength and route of administration were not provided). Co-suspect or concomitant therapies were not reported. The lot number reported for (Merck) VARIVAX was L001333 with expiration date on 13-Jan-2017. This is one of several reports from the same source. Additional information has been requested.
Information has been received from a consumer concerning her 4 year old son with no pertinent medical history and no known allergies who on 25-AUG-2009 was vaccinated with a dose of VARIVAX (Merck) (lot number not reported).  Secondary suspect vaccination therapy on the same day included a dose of MMR II (lot number not reported).  Concomitant therapy on the same day included poliovirus vaccine (manufacturer unspecified).  On 06-SEP-2009 the patient developed several chickenpox-like spots and on 07-SEP-2009 was covered in chickenpox.  Unspecified medical attention was sought.  There were no lab studies performed.  At the time of the report, the patient not recovered.  Additional information has been requested.
Got sick off the first dose of the vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of ILLNESS (Got sick off the first dose of the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got sick off the first dose of the vaccine). At the time of the report, ILLNESS (Got sick off the first dose of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not provided.  Treatment medication was not given.
sz-CT head negative lab (CBC, chem 18, CPR, Mg++ results all nl);
Redness from deltoid to mid forearm, 100% circumferented included initially, 2 days later redness spontaneously starting to regress. Positive swelling also regressing on 12 Jan 07.
Loss 0f appetite. excessive sleeping for 3 days. Light headed upon arising. body aches, coughing up thick mucus. condition lasting 9 days after covid19 shoot.
Covid 19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid 19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced COVID-19 (Covid 19). At the time of the report, COVID-19 (Covid 19) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided. Patient was told to wait for 90 days for his second shot as he got monoclonal antibodies infused on 04-MAR-2021.
9 minutes after receiving 1st dose of vaccine, client states "I feel different than I did before the shot".  When asked to explain, client reports headache, dizziness, chilled and face and neck were visibly flushed and warm.  VS were taken.  Client was 98-99% on RA with no respiratory distress.  HR was elevated at 110.  Denied chest pain.  Blood pressure was initially 130's/80's.  Client was assisted to clot to lie down and reports less dizziness at that point.  HR did return to 70-80's and blood pressure to 120's/70's.  Client continued to denies issues with breathing or chest pain.  Due to continued weakness, headache and dizziness, client was taken to ER at Hospital for evaluation
erythematous, pruritic area 5x8 cm inject site, itching globally; no SOB; no fever;
Information has been received from a physician concerning a 66 year old female who on 10-SEP-2007 was vaccinated with Zostavax (Oka/Merck).  Concomitant therapy included Pneumovax (MSD).  On 10-SEP-2007, the patient developed shingles type injection site rash.  The patient sough medical attention.  As of 13-SEP-2007, the patient was recovering.  Additional information has been requested.